My ENHERTU experience: video series

Juanita is living with HER2-positive metastatic breast cancer (mBC). Hear about her experience with ENHERTU.

Juanita is a patient living with mBC. The information in this video is based on her experiences at the time of filming. Not all patients' experiences are the same.

My name is Juanita. I'm a wife, I'm a mother, and I am a metastatic breast cancer patient.

When I think about who I am, the first thing I think of is being a mother.

I have a 10-year-old boy and two adult children.

Before I got my diagnosis, I knew something was wrong because I felt a lump in my breast. I was getting dressed and getting showered and I felt it.

I went on a few days later to have a mammogram and an ultrasound, and as soon as I saw the radiologist's face when she came back in, I knew something was going on.

And then we had more tests and more tests, and we got to the final diagnosis of stage four breast cancer.

When you hear stage four, you hear "This is not good."

When I was told that my breast cancer was HER2-positive, I didn't really know what that meant. So I did start to do research and learn about it.

Once I accepted it, it put me in a space of learning.

I was able to give myself the space to learn about the disease, to make sure I knew that I was getting the care that I needed. But I still wasn't able to give myself the care that I needed mentally and emotionally, until I connected with social support services. And that helped me to give myself the empathy and grace and gentleness that I needed, you know, to get through this every day.

My head was actually in a place where I'm going to die. But I got to know people who have been living with this and who knew so much and who were encouraging and uplifting.

When I learned about ENHERTU, and I started it, I became more motivated to take better care of myself.

I've tried a lot of different things to keep my body going and stronger. One of the things that I've tried is water aerobics. I have a great instructor and he makes it fun.

My advice for someone who is just starting ENHERTU would be, plan around your treatments. You plan meal prep around treatments, you plan grocery shopping around treatments. You plan hairdo, hairstyles, everything—you plan around your treatments. And that's hard to get used to in the beginning, too.

It's about managing how you feel. I take small naps all day long. That makes me ready for the evening, and I'm ready to go.

It affects everybody differently. I would tell another woman to talk to their doctor about what specific side effects they may have with ENHERTU, and what will be our plan to manage these side effects.

Have your questions prepared. The more that you know, the more confident you are in having conversations with your doctor.

During the pandemic, women of color, and just women in general, were able to connect in a different way than they ever had been before.

We connected just in support groups, talking to each other. We connected on cooking classes, blanket-making classes—all kinds of things.

I realized that sharing education with other women—and social support resources—became really important for me. So I began to share that with other women in any way that I could.

I want everybody to know how to speak up for themselves, and that they need to educate themselves about what's going on with them. Because it gives you a peace of mind to have a voice in what's going on.

And I didn't know that in the beginning. It took me a while to get to that place. It makes me lean on being stronger and braver and more confident than I've ever been. To be more present for myself. To live every day the best that I can.

Woman with loved one 4
Not actual patients.

About ENHERTU4U

The ENHERTU4U program is designed to help you access and afford your prescribed ENHERTU treatment, including benefits reviews, prior authorization and/or claims appeal information, and paying for your prescription.*

*For eligible patients. Terms and conditions apply.

Woman with loved one 4

What are some ways ENHERTU4U may be able to help after
I've been prescribed ENHERTU?

Access icon

Access

ENHERTU4U is here to help your healthcare provider understand your insurance company's requirements for access to treatment with ENHERTU.

Financial assistance icon

Financial assistance

We have multiple options to help you afford your treatment. Your healthcare provider can provide more information about how ENHERTU4U may be able to help.

For more information about ENHERTU4U,
please call 1-833-ENHERTU (1-833-364-3788)
or visit ENHERTU4U.com

ENHERTU4U does not guarantee access or cost savings for patients prescribed ENHERTU.

Are there resources I can download?

Download patient guide icon

Become more familiar with ENHERTU, including the potential benefits and side effects of treatment

Download patient guide

Connect with helpful resources

This is not an all-inclusive list of resources.

Sign up for information

Would you like to receive updates about ENHERTU?

What is ENHERTU?
ENHERTU is a prescription medicine used to treat adults who have:

  • human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by surgery or has spread to other parts of the body (metastatic) in combination with pertuzumab as your first treatment. Your healthcare provider will perform a test to make sure ENHERTU in combination with pertuzumab is right for you.
  • HER2-positive breast cancer that cannot be removed by surgery or that has spread to other parts of the body (metastatic), and who have received a prior anti-HER2 breast cancer treatment for metastatic disease or have breast cancer that has come back during or within 6 months of completing treatment for their early-stage breast cancer.

It is not known if ENHERTU is safe and effective in children.

What is the most important information I should know about ENHERTU?
ENHERTU can cause serious side effects, including:

  • Lung problems that may be severe, life-threatening or that may lead to death. If you develop lung problems your healthcare provider may treat you with corticosteroid medicines. Tell your healthcare provider right away if you get any of the following signs and symptoms:
    • cough
    • trouble breathing or shortness of breath
    • fever
    • other new or worsening breathing symptoms (such as chest tightness, wheezing)
  • Low white blood cell count (neutropenia). Low white blood cell counts are common with ENHERTU and can sometimes be severe. Your healthcare provider will check your white blood cell counts before starting ENHERTU and before starting each dose. Tell your healthcare provider right away if you develop any signs or symptoms of an infection or have fever or chills during treatment with ENHERTU.
  • Heart problems that may affect your heart's ability to pump blood. Your healthcare provider will check your heart function before starting treatment with ENHERTU. Tell your healthcare provider right away if you get any of the following signs and symptoms:
    • new or worsening shortness of breath
    • coughing
    • feeling tired
    • swelling of your ankles or legs
    • irregular heartbeat
    • sudden weight gain
    • dizziness or feeling light-headed
    • loss of consciousness

Your healthcare provider will check you for these side effects during your treatment with ENHERTU. Your healthcare provider may reduce your dose, delay treatment or completely stop treatment with ENHERTU if you have severe side effects.

  • Harm to your unborn baby. Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with ENHERTU.
    • If you are able to become pregnant, your healthcare provider should do a pregnancy test before you start treatment with ENHERTU.
    • Females who are able to become pregnant should use effective birth control (contraception) during treatment with ENHERTU and for 7 months after the last dose.
    • Males who have female partners who are able to become pregnant should use effective birth control (contraception) during treatment with ENHERTU and for 4 months after the last dose.

Before you receive ENHERTU, tell your healthcare provider about all of your medical conditions, including if you:

  • have lung or breathing problems
  • have signs or symptoms of an infection
  • have or have had any heart problems
  • are breastfeeding or plan to breastfeed. It is not known if ENHERTU passes into your breast milk. Do not breastfeed during treatment with ENHERTU and for 7 months after the last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive ENHERTU?

  • You will receive ENHERTU into your vein through an intravenous (IV) line by your healthcare provider.
  • ENHERTU is given 1 time every three weeks (21-day treatment cycle).
  • Your healthcare provider will decide how many treatments you need.
  • Your healthcare provider will give you medicines before your infusion to help prevent nausea and vomiting.
  • Your healthcare provider may slow down or temporarily stop your infusion of ENHERTU if you have an infusion-related reaction, or permanently stop ENHERTU if you have severe infusion reactions.
  • If you miss a planned dose of ENHERTU, call your healthcare provider right away to schedule an appointment. Do not wait until the next planned treatment cycle.

What are the possible side effects of ENHERTU?

ENHERTU can cause serious side effects. See "What is the most important information I should know about ENHERTU?"

The most common side effects of ENHERTU, when used alone at the 5.4 mg/kg dose in people with metastatic breast cancer, HER2-mutant non-small cell lung cancer, and other HER2-positive solid tumors include:

  • low white blood cell counts
  • nausea
  • low red blood cell counts
  • feeling tired
  • low platelet counts
  • increased liver function tests
  • vomiting
  • hair loss
  • constipation
  • low levels of blood potassium
  • decreased appetite
  • diarrhea
  • muscle or bone pain

The most common side effects of ENHERTU, when used in combination with pertuzumab at the 5.4 mg/kg dose in people with HER2-positive metastatic breast cancer include:

  • low white blood cell counts
  • low red blood cell counts
  • nausea
  • increased liver function tests
  • diarrhea
  • low platelet counts
  • low levels of blood potassium
  • feeling tired
  • hair loss
  • vomiting
  • upper respiratory tract infection
  • constipation
  • decreased appetite
  • weight loss
  • COVID-19
  • muscle or bone pain
  • stomach pain

ENHERTU may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.

These are not all of the possible side effects of ENHERTU. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide.

What is ENHERTU?
ENHERTU is a prescription medicine used to treat adults who have:

  • human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by surgery or has spread to other parts of the body (metastatic) in combination with pertuzumab as your first treatment. Your healthcare provider will perform a test to make sure ENHERTU in combination with pertuzumab is right for you.
  • HER2-positive breast cancer that cannot be removed by surgery or that has spread to other parts of the body (metastatic), and who have received a prior anti-HER2 breast cancer treatment for metastatic disease or have breast cancer that has come back during or within 6 months of completing treatment for their early-stage breast cancer.

It is not known if ENHERTU is safe and effective in children.